Mark Liddament Email & Phone Number

Mark Liddament, based in Parkville, VIC, AU, is currently a Director, Head of Antibody Discovery and Protein Engineering at CSL, bringing experience from previous roles at Teva Pharmaceuticals, OBodies Ltd., GlaxoSmithKline and MedImmune (formerly Cambridge Antibody Technology). Mark Liddament holds a 1999 - 2003 PhD in Biochemistry, Molecular Biology @ University of Cambridge. With a robust skill set that includes Protein Engineering, Drug Discovery, Antibody Engineering, Antibodies, Molecular Biology and more, Mark Liddament contributes valuable insights to the industry. Mark Liddament has 3 emails and 1 mobile phone number on RocketReach.